Pain for China stock funds, with strategists at Goldman, Credit Suisse confounded by PBOC’s token easing move
- China’s central bank lowered banks’ reserve ratio by only 25 basis points on Friday, the smallest cut in history, against expectations of a bigger shot in the arm
- Rolling lockdowns add second- and third-order hits to confidence, consumption and wage growth, diminishing the multiplier effect of large stimulus

The MSCI China Index, which tracks 742 stocks with a market value of US$2.2 trillion, fell 1.3 per cent last week. This year’s 15.5 per cent decline, including a dip to an eight-year low on March 15, is close to matching the 22 per cent fall last year as nine in every 10 China equity funds suffered losses in the last quarter.
“I’ll be surprised if we hit the March lows again, but we are not out of the woods yet,” said Kiran Nandra, head of emerging-market equities at Pictet Asset Management. “We will need to see a bit more concrete signals. Even signalling on Covid-induced lockdowns would go a huge way to lower the risk premium.”
The RRR cut, which unleashes 530 billion yuan (US$83.2 billion) of liquidity, generates “too small and too late” savings to spur a cut in lending rate, Goldman Sachs economists said in a note on April 16. It no longer expects the PBOC to cut policy rate or deliver further RRR cuts in its baseline scenario.
